The Agenda

Credit: SCIENCE SOURCE / PHOTO RESEARCHERS, INC." /> Credit: SCIENCE SOURCE / PHOTO RESEARCHERS, INC. OLD-TIME DRUG DISCOVERY >> Had he lived, penicillin co-discoverer Alexander Fleming would have turned 125 on August 6, and to celebrate, he could have keynoted the 11th annual Drug Discovery Technology conference in Boston from August 7-10. For more, see www.drugdisc.com/section.asp.BUILDING ECOCITIES >> If the lab design feature on page 40 gets your architectural ju

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

OLD-TIME DRUG DISCOVERY >> Had he lived, penicillin co-discoverer Alexander Fleming would have turned 125 on August 6, and to celebrate, he could have keynoted the 11th annual Drug Discovery Technology conference in Boston from August 7-10. For more, see www.drugdisc.com/section.asp.

BUILDING ECOCITIES >> If the lab design feature on page 40 gets your architectural juices flowing, why not go to Ecocity 6 in Bangalore, India from August 5-12 to learn how to build sustainable cities of the future.
(EDITOR?S NOTE: After press time, this meeting was postponed until November. Please visit www.tciconferences.com/ecocity2006/ecocity2006.htm for an updated schedule.)

CONTROLLING MERCURY >> Last year in our pages, Larry Schweiger called for coal-fired power plants - the largest uncontrolled source of mercury in the US - to control 90% of their mercury emissions. That move "is essential to accelerate progress toward making our fish safe to eat," he wrote in our October 24, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies